 PHILADELPHIA, Sept. 27, 2021 GLOBE NEWSWIRE -- Passage Bio, Inc. NASDAQ: PASG, a genetic medicines company focused on developing transformative therapies for central nervous system CNS disorders, today announced that management will participate in two upcoming conferences in October: 